Clinical Trial: DZD9008 PK Study in Hepatic Impairment Subjects
Study Status: Completed
Recruit Status: RECRUITING
Condition: Hepatic Impairment
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Single-Dose, Non-Randomized, Open Label Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of DZD9008
Brief Summary:
This study will investigate the pharmacokinetics, safety, and tolerability of DZD9008 in subjects with hepatic impairment compared to subjects with normal hepatic function
Read more